{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:38:49Z","timestamp":1787859529220,"version":"build-2784847793"},"reference-count":41,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00154"],"award-info":[{"award-number":["PI20\/00154"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Perioperative myocardial injury (PMI) is a common complication following non-cardiac, particularly thoracic, surgery and is associated with increased cardiovascular risk. Although guidelines recommend cardiac biomarker monitoring to detect PMI, its implementation in routine clinical practice remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the combined use of high-sensitivity cardiac troponin I (hs-cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting major adverse cardiovascular events (MACE) following elective thoracic surgery, and to determine whether NT-proBNP provides incremental prognostic value beyond hs-cTnI alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicentre observational cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Conducted between February 2021 and November 2023 in three Spanish tertiary hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients aged \u226545 years scheduled for elective thoracic surgery involving lung resection (pneumonectomy, lobectomy, bilobectomy or segmentectomy) under general anaesthesia. Exclusion criteria included urgent or non-thoracic surgery, active infection or sepsis and a history of severe heart failure (ejection fraction &lt;30%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Combined measurement of hs-cTnI and NT-proBNP at baseline (preoperatively) and at 24 and 48 hours postoperatively.<\/jats:p>\n                    <jats:p>PMI was defined as hs-cTnI \u226545 ng\/L at 24 and\/or 48 hours or a \u226520% increase from baseline in patients with elevated preoperative concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 475 patients, PMI occurred in 11.8%. PMI had higher rates of prior stroke (12.5% vs 2.9%; p=0.004), smoking history (85.7% vs 64.0%; p=0.001) and severe renal dysfunction (7.1% vs 0.7%; p=0.001), with similar Revised Cardiac Risk Index distribution. Patients with PMI also had greater postoperative elevations of hs-cTnI and NT-proBNP (p&lt;0.001), longer surgeries (3.5 hours vs 2.7\u2009hours; p&lt;0.001) and more frequent lobectomy\/bilobectomy (64.3% vs 50.4%; p&lt;0.001). Robotic-assisted thoracic surgery (RATS) was associated with increased PMI risk (OR 2.29; p=0.019). Among 49 patients (10.3%) with dual postoperative elevation of hs-cTnI and NT-proBNP, cardiovascular comorbidities were common (hypertension 81.6%, smoking history 85.7%, stroke 14.3%), and most procedures were minimally invasive (video-assisted thoracic surgery 61.2%, RATS 24.5%), with a median duration of 3\u2009hours 42\u2009min. MACE occurred in 18.4% of this group, indicating a substantially elevated risk than isolated or no biomarker elevations. At 30 days, patients with PMI had higher MACE (14.3% vs 3.3%; p&lt;0.001), mortality (3.6% vs 0.7%; p=0.049) and new-onset arrhythmias (5.3% vs 0.2%; p&lt;0.001), particularly atrial fibrillation (7.1% vs 1.7%; p=0.011). Dual biomarker elevation was associated with the highest MACE risk (15.2%), representing a twofold to threefold increase over single biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined hs-cTnI and NT-proBNP assessment improves perioperative cardiovascular risk stratification beyond ischaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04749212\">NCT04749212<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108073","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:25:35Z","timestamp":1776435935000},"page":"e108073","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct04749212","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04749212","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mar\u00eda","family":"Alonso","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Hospital Vall d\u2019Hebron, Barcelona, Spain"},{"name":"Faculty of Medicine, Department of Surgery and Morphological Sciences, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8781-9873","authenticated-orcid":false,"given":"Ekaterine","family":"Popova","sequence":"additional","affiliation":[{"name":"Institut de Recerca Sant Pau, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"De Miguel","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Hospital Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Garc\u00eda-Osuna","sequence":"additional","affiliation":[{"name":"Institut de Recerca Sant Pau, Barcelona, Spain"},{"name":"Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6509-6777","authenticated-orcid":false,"given":"Anna","family":"Gonzalez-Tallada","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Hospital Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Ordo\u00f1ez-Llanos","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"},{"name":"Foundation for Clinical Biochemistry & Molecular Pathology, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Jauregui","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and Lung Transplantation, Hospital Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Trujillo","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ascensi\u00f3n","family":"Martin Grande","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Mart\u00ednez-T\u00e9llez","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Parera","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Planas","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Trujillo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Butron","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Hospital Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Sol\u00e0-Roca","sequence":"additional","affiliation":[{"name":"Institut de Recerca Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"De Nadal","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Hospital Vall d\u2019Hebron, Barcelona, Spain"},{"name":"Faculty of Medicine, Department of Surgery and Morphological Sciences, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2026041707252049000_16.4.e108073.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.4360"},{"key":"2026041707252049000_16.4.e108073.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030114"},{"key":"2026041707252049000_16.4.e108073.3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(18)33139-8","article-title":"Global burden of postoperative death","volume":"393","author":"Nepogodiev","year":"2019","journal-title":"The Lancet"},{"key":"2026041707252049000_16.4.e108073.4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/anae.12635","article-title":"Cardiac biomarkers in the prediction of risk in the non\u2010cardiac surgery setting","volume":"69","author":"Biccard","year":"2014","journal-title":"Anaesthesia"},{"key":"2026041707252049000_16.4.e108073.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac798"},{"key":"2026041707252049000_16.4.e108073.6","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000113"},{"key":"2026041707252049000_16.4.e108073.7","unstructured":"Buse GL , Pinto BB , Abelha F , et al . ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation. 2023. Available: http:\/\/links.lww.com\/EJA\/A845"},{"key":"2026041707252049000_16.4.e108073.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac270"},{"key":"2026041707252049000_16.4.e108073.9","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrad021","article-title":"Long-term major adverse cardiovascular events following myocardial injury after non-cardiac surgery: meta-analysis","volume":"7","author":"Strickland","year":"2023","journal-title":"BJS Open"},{"key":"2026041707252049000_16.4.e108073.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01827-w"},{"key":"2026041707252049000_16.4.e108073.11","first-page":"110","article-title":"Evaluation of perioperative high-sensitive cardiac troponin I as a predictive biomarker of major adverse cardiovascular events after noncardiac surgery","volume":"72","author":"Mill\u00e1n-Figueroa","year":"2020","journal-title":"Rev Invest Clin"},{"key":"2026041707252049000_16.4.e108073.12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.jvca.2019.08.014","article-title":"Myocardial Injury After Noncardiac Surgery: Incidence, Predictive Factors, and Outcome in High-Risk Patients Undergoing Thoracic Surgery: An Observational Study","volume":"34","author":"Gonz\u00e1lez-Tallada","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2026041707252049000_16.4.e108073.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2022.06.035"},{"key":"2026041707252049000_16.4.e108073.14","article-title":"AHA\/ACC Guideline for the perioperative cardiovascular evaluation and management of patients undergoing non-cardiac surgery","volume":"149","author":"Fleisher","year":"2024","journal-title":"Circulation"},{"key":"2026041707252049000_16.4.e108073.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.09.008"},{"key":"2026041707252049000_16.4.e108073.16","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuaa008"},{"key":"2026041707252049000_16.4.e108073.17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjmed.2016.01.013","article-title":"Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine","volume":"129","author":"Wettersten","year":"2016","journal-title":"Am J Med"},{"key":"2026041707252049000_16.4.e108073.18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006541","article-title":"Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction","volume":"13","author":"R\u00f8rth","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026041707252049000_16.4.e108073.19","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31820f286f"},{"key":"2026041707252049000_16.4.e108073.20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5090\/kjtcs.2011.44.1.44","article-title":"N-Terminal Pro-B-type Natriuretic Peptide Is Useful to Predict Cardiac Complications Following Lung Resection Surgery","volume":"44","author":"Lee","year":"2011","journal-title":"Korean J Thorac Cardiovasc Surg"},{"key":"2026041707252049000_16.4.e108073.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121306","article-title":"Prediction of Perioperative Cardiac Events through Preoperative NT-pro-BNP and cTnI after Emergent Non-Cardiac Surgery in Elderly Patients","volume":"10","author":"Ma","year":"2015","journal-title":"PLoS ONE"},{"key":"2026041707252049000_16.4.e108073.22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.647008"},{"key":"2026041707252049000_16.4.e108073.23","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jtcvs.2019.01.075","article-title":"A brain natriuretic peptide-based prediction model for atrial fibrillation after thoracic surgery: Development and internal validation","volume":"157","author":"Amar","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026041707252049000_16.4.e108073.24","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu348"},{"key":"2026041707252049000_16.4.e108073.25","first-page":"19","article-title":"Cardiac biomarkers predicting major adverse cardiovascular events in patients undergoing noncardiac surgery: a meta-analysis","volume":"6","author":"Zhang","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2026041707252049000_16.4.e108073.26","first-page":"768","article-title":"Using preoperative N-terminal pro-B-type natriuretic peptide levels for predicting major adverse cardiovascular events and myocardial injury after noncardiac surgery in Chinese advanced-age patients","volume":"19","author":"Zhang","year":"2022","journal-title":"J Geriatr Cardiol"},{"key":"2026041707252049000_16.4.e108073.27","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.3390\/ijerph19095182","article-title":"Natriuretic Peptides and Troponins to Predict Cardiovascular Events in Patients Undergoing Major Non-Cardiac Surgery","volume":"19","author":"Perrone","year":"2022","journal-title":"IJERPH"},{"key":"2026041707252049000_16.4.e108073.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063778","article-title":"Study protocol for an observational cohort evaluating incidence and clinical relevance of perioperative elevation of high-sensitivity troponin I and N-terminal pro-brain natriuretic peptide in patients undergoing lung resection","volume":"12","author":"Alonso","year":"2022","journal-title":"BMJ Open"},{"key":"2026041707252049000_16.4.e108073.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"2026041707252049000_16.4.e108073.30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.rce.2016.02.008","article-title":"Documento de consenso y recomendaciones sobre el uso de los p\u00e9ptidos natriur\u00e9ticos en la pr\u00e1ctica cl\u00ednica","volume":"216","author":"Pascual-Figal","year":"2016","journal-title":"Revista Cl\u00ednica Espa\u00f1ola"},{"key":"2026041707252049000_16.4.e108073.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2011.06.007"},{"key":"2026041707252049000_16.4.e108073.32","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezv154"},{"key":"2026041707252049000_16.4.e108073.33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs154"},{"key":"2026041707252049000_16.4.e108073.34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cjco.2025.04.008","article-title":"Smoking, Colchicine and Postoperative Outcomes in Thoracic Surgery: Post Hoc Analysis of the COP-AF Randomized Controlled Trial","volume":"7","author":"Ofori","year":"2025","journal-title":"CJC Open"},{"key":"2026041707252049000_16.4.e108073.35","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12020276","article-title":"Troponin Cut-Offs for Acute Myocardial Infarction in Patients with Impaired Renal Function-A Systematic Review and Meta-Analysis","volume":"12","author":"Kampmann","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026041707252049000_16.4.e108073.36","article-title":"The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery","volume":"12","author":"Vernooij","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026041707252049000_16.4.e108073.37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bja.2021.10.006","article-title":"Identification of myocardial injury using perioperative troponin surveillance in major noncardiac surgery and net benefit over the Revised Cardiac Risk Index","volume":"128","author":"Chew","year":"2022","journal-title":"Br J Anaesth"},{"key":"2026041707252049000_16.4.e108073.38","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(23)01689-6","article-title":"Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial","volume":"402","author":"Conen","year":"2023","journal-title":"The Lancet"},{"key":"2026041707252049000_16.4.e108073.39","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1213\/ANE.0000000000006469","article-title":"Prediction of Acute Myocardial Injury in Noncardiac Surgery in Patients at Risk for Major Adverse Cardiovascular and Cerebrovascular Events: A Multivariable Risk Model","volume":"137","author":"Mases","year":"2023","journal-title":"Anesth Analg"},{"key":"2026041707252049000_16.4.e108073.40","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13020333","article-title":"Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence","volume":"13","author":"M\u00e9ndez Hern\u00e1ndez","year":"2023","journal-title":"J Pers Med"},{"key":"2026041707252049000_16.4.e108073.41","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-319511"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:25:41Z","timestamp":1776435941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2025-108073"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108073","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}